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Abstract
Genome-wide association studies (GWAS) have been widely used to examine the
association between single nucleotide polymorphisms (SNPs) and complex traits, where
both the sample size n and the number of SNPs p can be very large. Recently, cross-trait
polygenic risk score (PRS) method has gained extremely popular for assessing genetic
correlation of complex traits based on GWAS summary statistics (e.g., SNP effect
size). However, empirical evidence has shown a common bias phenomenon that even
highly significant cross-trait PRS can only account for a very small amount of genetic
variance (R2 often < 1%). The aim of this paper is to develop a novel and powerful
method to address the bias phenomenon of cross-trait PRS. We theoretically show that
the estimated genetic correlation is asymptotically biased towards zero when complex
traits are highly polygenic/omnigenic. When all p SNPs are used to construct PRS, we
show that the asymptotic bias of PRS estimator is independent of the unknown number
of causal SNPs m. We propose a consistent PRS estimator to correct such asymptotic
bias. We also develop a novel estimator of genetic correlation which is solely based
on two sets of GWAS summary statistics. In addition, we investigate whether or not
SNP screening by GWAS p-values can lead to improved estimation and show the effect
of overlapping samples among GWAS. Our results may help demystify and tackle the
puzzling “missing genetic overlap” phenomenon of cross-trait PRS for dissecting the
genetic similarity of closely related heritable traits. We illustrate the finite sample
performance of our bias-corrected PRS estimator by using both numerical experiments
and the UK Biobank data, in which we assess the genetic correlation between brain
white matter tracts and neuropsychiatric disorders.
Keywords. Summary statistics; Genetic correlation; Polygenic risk score; GWAS;
Omnigenic; Polygenic; Marginal screening; Bias correction.
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1 Introduction
The major aim of many genome-wide association studies (GWAS) [Visscher et al.,
2017] is to examine the genetic influences on complex human traits given that most
traits have a polygenic architecture [Fisher, 1919, Gottesman and Shields, 1967, Hill,
2010, Orr and Coyne, 1992, Penrose, 1953, Wray et al., 2018]. That is, a large number
of single nucleotide polymorphisms (SNPs) have small but nonzero contributions to
the phenotypic variation. Many statistical methods have been developed on the use
of individual-level GWAS SNP data to infer the heritability and cross-trait genetic
correlation in general populations [Chen, 2014, Golan et al., 2014, Guo et al., 2017b,
Jiang et al., 2016, Lee and Van der Werf, 2016, Lee et al., 2012, Loh et al., 2015, Yang
et al., 2010, 2011]. For instance, heritability h2 can be estimated by aggregating the
small contributions of a large number of SNP markers, resulting in the SNP heritability
estimator [Yang et al., 2017]. For two highly polygenic traits, cross-trait genetic corre-
lation can be calculated as the correlation of the genetic effects of numerous SNPs on
the two traits [Guo et al., 2017b, Lu et al., 2017, Pasaniuc and Price, 2017, Shi et al.,
2017]. A growing number of empirical evidence [Chatterjee et al., 2016, Dudbridge,
2016, Ge et al., 2017, Shi et al., 2016, Yang et al., 2010] supports the polygenicity of
many complex human traits and verify that the common (minor allele frequency [MAF]
≥ 0.05) SNP can account for a large amount of heritability of many complex traits. The
term “omnigenic” has been introduced to acknowledge the widespread causal genetic
variants contributing to various complex human traits [Boyle et al., 2017].
Accessing individual-level SNP data is often inconvenient due to policy restrictions,
and a recent standard practice in the genetic community is to share the summary
association statistics, including the estimated effect size, standard error, p-value, and
sample size n, of all genotyped SNPs after GWAS are published [MacArthur et al.,
2016, Zheng et al., 2017]. Therefore, joint analysis of summary-level data of different
GWAS provides new opportunities for further analyses and novel genetic discoveries,
such as the shared genetic basis of complex traits. It has became an active research
area to examine the heritability and cross-trait genetic correlation based on GWAS
summary statistics [Bulik-Sullivan et al., 2015a,b, Dudbridge, 2013, Lee et al., 2013,
Lu et al., 2017, Palla and Dudbridge, 2015, Shi et al., 2017, Weissbrod et al., 2018,
Zhou, 2017]. Among them, the cross-trait polygenic risk score (PRS) [Power et al.,
2015, Purcell et al., 2009] has became a popular routine to measure genetic similarity
of polygenic traits with widespread applications [Bogdan et al., 2018, Clarke et al.,
2016, Hagenaars et al., 2016, Mistry et al., 2018, Nivard et al., 2017, Pouget et al.,
2018, Socrates et al., 2017]. Compared with other popular methods such as cross-trait
LD score regression [Bulik-Sullivan et al., 2015a], Bivariate GCTA [Lee et al., 2012], and
BOLT-REML [Loh et al., 2015], cross-trait PRS offers at least two unique strengths as
follows. First, cross-trait PRS only requires the GWAS summary statistics of one trait
obtained from a large discovery GWAS, while it allows those of the other trait obtained
from a much smaller GWAS dataset. In contrast, most other methods require large
GWAS data for both traits on either summary or individual-level. Second, cross-trait
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PRS can provide genetic propensity for each sample in the testing dataset, enabling
further prediction and treatment. However, given these strengths of cross-trait PRS,
empirical evidence has shown a common bias phenomenon that even highly significant
cross-trait PRS can only account for a very small amount of variance (R2 often < 1%)
when dissecting the shared genetic basis among highly related heritable traits [Bogdan
et al., 2018, Clarke et al., 2016, Mistry et al., 2018, Socrates et al., 2017]. Except for
some introductory studies [Daetwyler et al., 2008, Dudbridge, 2013, Visscher et al.,
2014], few attempts have ever been made to rigorously study cross-trait PRS and to
explain such a counterintuitive phenomenon.
This paper fills this significant gap with the following contributions. By compre-
hensively investigating the properties of cross-trait PRS for polygenic/omnigenic traits,
our first contribution in Section 2 is to show that the estimated genetic correlation is
asymptotically biased towards zero, uncovering that the underlying genetic overlap is
seriously underestimated. Furthermore, when all p SNPs are used in cross-trait PRS,
we show that the asymptotic bias is largely determined by the triple (n, p, h2) and
is independent of the unknown number of causal SNPs of the two traits. Thus, our
second contribution in Section 2 is to propose a consistent estimator by correcting
such asymptotic bias in cross-trait PRS. We also develop a novel estimator of genetic
correlation which only requires two sets of summary statistics.
Next, in Section 3, we show that when cross-trait PRS is constructed using q top-
ranked SNPs whose GWAS p-values pass a given threshold, in addition to (n, p, h2),
the asymptotic bias will also be determined by the number of causal SNPs m, since the
sparsity m/p determines the quality of the q selected SNPs. Particularly, for highly
polygenic/omnigenic traits with dense SNP signals, such screening may fail, resulting
in larger bias in genetic correlation estimation. In Section 4, we generalize our results
to quantify the influence of overlapping samples among GWAS. We show that our bias-
corrected estimator for independent GWAS can be smoothly extended to GWAS with
partially or even fully overlapping samples.
The remainder of this paper is structured as follows. Sections 2 and 3 study the
cross-trait PRS with all SNPs and selected SNPs, respectively. Section 4 considers
the effect of overlapping samples among different GWAS. Sections 5 and 6 summarize
the numerical results on numerical experiments and real data analysis. The paper
concludes with some discussions in Section 7.
2 Cross-trait PRS with all SNPs
Since cross-trait PRS is designed for polygenic traits based on their GWAS summary
statistics, we first introduce the polygenic model and some properties of GWAS sum-
mary statistics. We note that the standard approach in GWAS is marginal screening.
That is, the marginal association between the phenotype and single SNP is assessed
each at a time, while adjusting for the same set of covariates including population
stratification [Price et al., 2006]. Marginal screening procedures often work well to
prioritize important variables given that the signals are sparse [Fan and Lv, 2008], but
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they may have noisy outcomes when signals are dense [Fan et al., 2012], which is often
the case for GWAS of highly polygenic traits.
2.1 Polygenic trait and GWAS summary statistics
Let X(1) be an n ×m matrix of the SNP data with nonzero effects, and X(2) be an
n× (p−m) matrix of the null SNPs, resulting in an n× p matrix of all SNPs, donated
by X = [X(1),X(2)] = (x1, · · · ,xm,xm+1, · · · ,xp), where xi is an n × 1 vector of
the SNP i, i = 1, · · · , p. Columns of X are assumed to be independent after linkage
disequilibrium (LD)-based pruning. Further, we assume column-wise normalization on
X is performed such that each variable has sample mean zero and sample variance
one. Therefore, we may introduce the following condition on SNP data:
Condition 1. Entries ofX = [X(1),X(2)] are real-value independent random variables
with mean zero, variance one and a finite eighth order moment.
Let y be an n × 1 vector of continuous polygenic phenotype. We assume a linear
polygenic structure between y and X as follows:
y =
p∑
i=1
xiβi +  =
m∑
i=1
xiβi +  = X(1)β(1) + , (1)
where β = (β1, · · · , βm, βm+1, · · · , βp)T =
(
βT(1),β
T
(2)
)
is a vector of genetic effects
such that βi in β
T
(1) = (β1, · · · , βm)T are random variables (i = 1, · · · ,m), βT(2) =
(βm+1, · · · , βp)T are zeros, and  represents the vector of independent non-genetic
random errors. For simplicity, we assume that there are no other fixed effects in
model (1), or equivalently, other covariates can be well observed and adjusted for.
We allow flexible ratios among (n, p,m). As min(n, p)→∞, we assume
m
n
= γ → γ0 and m
p
= ω → ω0 for 0 < γ0 ≤ ∞ and 0 ≤ ω0 ≤ 1,
which should satisfy most large-scale GWAS of polygenic traits. Most GWAS use
ordinary least squares (OLS) to perform linear regression given by
y = 1nµ+ xiβi + 
∗
i (2)
for i = 1, · · · , p, where 1n is an n×1 vector of ones. Let µ̂ and β̂i be the OLS estimates
of µ and βi, respectively, for i = 1, · · · , p. When y and xi are normalized and both n
and m→∞, under Condition 1 and model (1), it can be shown that
E
(
µ̂
)
= 0, E
(
β̂i
)
= βi, and
Var
(
β̂i
)
=
{
n−1 ·∑mj 6=i β2j = O(m/n), for i ∈ [1,m];
n−1 ·∑mj=1 β2j = O(m/n), for i ∈ [m+ 1, p]. (3)
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Fig. 1: Estimation (upper panels) and testing (bottom panels) of
marginal genetic effects in GWAS of polygenic traits. We set n = 10, 000
and m = p = 100, 1000 and 5000.
Equation (3) indicates that the variance or mean squared error (MSE) of β̂i calculated
from model (2) moves up linearly as m→∞. Therefore, the T scores for testing
H0i : βi = 0 versus H1i : βi 6= 0, for i = 1, · · · , p
are given by
Ti =
{
β̂i/(
∑m
j 6=i β
2
j /n)
1/2 = β̂i ·O(
√
n/m), for i ∈ [1,m];
β̂i/(
∑m
j=1 β
2
j /n)
1/2 = β̂i ·O(
√
n/m), for i ∈ [m+ 1, p]
under H0i, i = 1, · · · , p.
Remark 1. The above simple derivations reveal important insights into the challenge
of performing marginal screening for polygenic traits. For estimation, although β̂is
are all unbiased given that X are independent, Var(β̂i) is O(m/n) instead of O(1/n).
Therefore, when m/n is large, the variance (and MSE) of β̂is can be so overwhelming
that β̂is might be dominated by their standard errors. Note that all Var(β̂i)s are in
the same scale regardless of whether their original βis are zeros or not. Thus, the β̂is
from causal and null variants can be totally mixed up when m/n is large. In addition,
the test statistics Tis may not well preserve the ranking of variables in X when m/n
is large, resulting in potential low power and high false positive rate in detecting and
prioritizing important SNPs.
Figure 1 demonstrates the estimation and testing of marginal genetic effects in
GWAS with n = 10, 000 as p = m increases from 100, 1000 to 5000. Each entry of X
5
is i.i.d generated from N(0, 1), elements of β(1) are i.i.d generated from N(0, 0.4), and
entries of  are i.i.d from N(0, 1). Then, y is generated from model (1). The estimated
genetic effects are unbiased in general, however, the uncertainty clearly moves up as
m increases. The relative contribution of each SNP decreases as m increases, and thus
the testing power drops as well. More simulations on GWAS summary statistics can
be found in Section 5.
As illustrated in later sections, these properties of GWAS summary statistics are
closely related to the asymptotic bias of cross-trait PRS and the performance of SNP
screening. Specifically, i) when cross-trait PRS is constructed with all p SNPs, the
p Var
(
β̂i
)
s are aggregated, resulting in inflated genetic variance and underestimated
genetic correlation; and ii) when cross-trait PRS is constructed with top-ranked SNPs
that pass a pre-specified p-value threshold, it may have worse performance if GWAS
marginal screening fails to prioritize the causal SNPs.
2.2 General setup
In this subsection, we introduce the modelling framework to investigate the cross-
trait PRS, including the genetic architecture of polygenic traits, distribution of genetic
effects, and genetic correlation estimators.
2.2.1 Polygenic traits
Consider three independent GWAS that are conducted for three different traits as
follows:
• Discovery GWAS-I: (X,yα), with X = [X(1),X(2)] ∈ Rn1×p, X(1) ∈ Rn1×mα ,
and yα ∈ Rn1×1.
• Discovery GWAS-II: (Z,yβ), with Z = [Z(1),Z(2)] ∈ Rn2×p, Z(1) ∈ Rn2×mβ , and
yβ ∈ Rn2×1.
• Target testing GWAS: (W ,yη), withW = [W(1),W(2)] ∈ Rn3×p,W(1) ∈ Rn3×mη ,
and yη ∈ Rn3×1.
Here yα, yβ, and yη are three different continuous phenotypes studied in three GWAS
with sample sizes n1, n2, and n3, respectively. Thus, mα, mβ, and mη are different
numbers of causal SNPs in general. The X(1), Z(1), and W(1) denote the causal SNPs
of yα, yβ, and yη, respectively, and X(2), Z(2), and W(2) donate the corresponding
null SNPs. Thus, X, Z, and W are three matrices of p SNPs. It is assumed that X,
Z, and W have been normalized and satisfy Condition 1. Similar to model (1), the
linear polygenic model assumes
yα = Xα+ α, yβ = Zβ + β, and yη = Wη + η, (4)
where α, β, and η are p × 1 vectors of SNP effects, and α, β, and η represent
independent random error vectors. The overall genetic heritability of yα is, therefore,
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given by
h2α =
Var(Xα)
Var(yα)
=
Var(X(1)α(1))
Var(X(1)α(1)) + Var(α)
,
which measures the proportion of variation in yα that can be explained by the genetic
variation Xα. The yα is fully heritable when h
2
α = 1. Similarly, we can define the
heritability h2β of yβ and h
2
η of yη, respectively. We assume h
2
α, h
2
β, and h
2
η ∈ (0, 1].
The genetic correlation in this paper is defined as the correlation of SNP effects on
pairs of phenotypes [Guo et al., 2017b, Lu et al., 2017, Pasaniuc and Price, 2017, Shi
et al., 2017].
Definition 1 (Genetic Correlation). The genetic correlation between yα and yη and
that between yα and yβ are respectively given by
ϕαη =
αTη
‖α‖ · ‖η‖ · I(‖α‖ · ‖η‖ > 0) and ϕαβ =
αTβ
‖α‖ · ‖β‖ · I(‖α‖ · ‖β‖ > 0),
where I(·) is the indicator function, ‖ · ‖ is the l2 norm of a vector, and ϕαη and
ϕαβ ∈ [−1, 1].
2.2.2 Genetic effects
Since mα, mβ and mη can be different and the causal SNPs of different phenotypes
may partially overlap, we let mαη be the number of overlapping causal SNPs of yα and
yη, and mαβ be the number of overlapping causal SNPs of yα and yβ. Let F (0, V )
represent a generic distribution with mean zero, (co)variance V , and finite fourth order
moments. Without loss of generality, we introduce the following condition on genetic
effects and random errors.
Condition 2. αi, βj , and ηk are independent random variables satisfying
αi ∼ F (0, σ2α), i = 1, ...,mα; βj ∼ F (0, σ2β), j = 1, ...,mβ;
ηk ∼ F (0, σ2η), k = 1, ...,mη.
The mαη overlapping nonzero effects (αi, ηi)s of (yα,yη) and mαβ overlapping nonzero
effects (αj , βj)s of (yα,yβ) satisfy(
αi
ηi
)
∼ F
[(
0
0
)
,
(
σ2α σαη
σαη σ
2
η
)]
and
(
αj
βj
)
∼ F
[(
0
0
)
,
(
σ2α σαβ
σαβ σ
2
β
)]
,
respectively. And αi , βj and ηk are independent random variables satisfying
αi ∼ F (0, σ2α), i = 1, ..., n1; βj ∼ F (0, σ2β ), j = 1, ..., n2;
ηk ∼ F (0, σ2η), k = 1, ..., n3;
where σαη = ραη · σαση and σαβ = ραβ · σασβ.
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Since the three GWAS have independent samples, we assume that their random
errors are independent. Overlapping samples and the induced non-genetic correlation
will be studied in Section 4. Under Condition 2, when n1, n3, and p→∞, if mαη,mα,
and mη → ∞, and mαη/√mαmη = καη → κ0αη ∈ (0, 1], then the genetic correlation
between yα and yη is asymptotically given by
ϕαη =
αTη
‖α‖ · ‖η‖ =
∑mαη
i=1 αiηi
(
∑mα
i=1 α
2
i )
1/2(
∑mη
i=1 η
2
i )
1/2
=
mαη
(mαmη)1/2
· ραη · {1 + o(1)} = κ0αη · ραη · {1 + o(1)}.
Similarly, when n1, n2, n3, and p→∞, if mαβ,mα, and mβ →∞ and mαβ/√mαmβ =
καβ → κ0αβ ∈ (0, 1], then the genetic correlation between yα and yβ is asymptotically
given by
ϕαβ =
αTβ
‖α‖ · ‖β‖ =
mαβ
(mαmβ)1/2
· ραβ · {1 + o(1)} = κ0αβ · ραβ · {1 + o(1)}.
As in Jiang et al. [2016], heritability h2α, h
2
β, and h
2
η can be asymptotically represented
as follows:
h2α =
mασ
2
α
mασ2α + σ
2
α
, h2β =
mβσ
2
β
mβσ
2
β + σ
2
β
, and h2η =
mησ
2
η
mησ2η + σ
2
η
.
2.2.3 Genetic correlation estimators
Now we introduce the cross-trait PRS and genetic correlation estimators. We need the
following data. As n1, n2, and p → ∞, the summary association statistics for yα and
yβ from Discovery GWAS-I & II are given by
α̂ =
1
n1
XT
(
X(1)α(1) + α
)
and β̂ =
1
n2
ZT
(
Z(1)β(1) + β
)
.
We assume that the individual-level SNP W and phenotype yη in the Target testing
GWAS can be accessed. In addition, h2α, h
2
β, and h
2
η are assumed to be estimable,
using either their corresponding individual-level data [Loh et al., 2015, Yang et al.,
2011] or summary-level data [Bulik-Sullivan et al., 2015b, Palla and Dudbridge, 2015,
Weissbrod et al., 2018], or can be found in the literature [Polderman et al., 2015]. In
summary, besides (n1, n2, n3, p), it is assumed that α̂, β̂, W , yη, ĥ
2
α, ĥ
2
β, and ĥ
2
η are
available.
We construct cross-trait PRSs as follows:
Ŝα =
p∑
i=1
wiâi = Wâ = W(1,α)â(1) +W(2,α)â(2) for yα and
Ŝβ =
p∑
i=1
wib̂i = Wb̂ = W(1,β)b̂(1) +W(2,β)b̂(2) for yβ,
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where â = (â1, · · · , âmα , âmα+1, · · · , âp)T =
(
â T(1), â
T
(2)
)
, in which âi = α̂i · I(|α̂i| >
cα), b̂ = (̂b1, · · · , b̂mβ , b̂mβ+1, · · · , b̂p)T =
(
b̂ T(1), b̂
T
(2)
)
, in which b̂i = β̂i · I(|β̂i| > cβ),
and cα and cβ are given thresholds used for SNP screening in order to calculate Ŝα
and Ŝβ. Moreover, we define W(1,α) = [w1, · · · ,wmα ], W(2,α) = [wmα+1, · · · ,wp],
W(1,β) = [w1, · · · ,wmβ ], W(2,β) = [wmβ+1, · · · ,wp], and W = [W(1,α),W(2,α)] =
[W(1,β),W(2,β)].
We estimate the genetic correlation between yα and yη with
(
Ŝα,yη
)
and that
between yα and yβ with
(
Ŝα,Ŝβ
)
. They represent two common cases in real data
applications. For
(
Ŝα,yη
)
, individual-level data are available for one trait, but not for
another one. It often occurs when the traits are studied in two different GWAS. For(
Ŝα,Ŝβ
)
, neither of the two traits has individual-level data. This happens when we
have GWAS summary statistics of two traits and estimate their genetic correction on
an independent target dataset. The genetic correlation estimators are given by
Gαη =
yTη Ŝα∥∥yη∥∥ · ∥∥Ŝα∥∥ =
(
W(1)η(1) + η
)T (
W(1,α)â(1) +W(2,α)â(2)
)∥∥W(1)η(1) + η∥∥ · ∥∥W(1,α)â(1) +W(2,α)â(2)∥∥
for ϕαη, and
Gαβ =
ŜTβ Ŝα∥∥Ŝβ∥∥ · ∥∥Ŝα∥∥ =
(
W(1,β)b̂(1) +W(2,β)b̂(2)
)T (
W(1,α)â(1) +W(2,α)â(2)
)∥∥W(1,β)b̂(1) +W(2,β)b̂(2)∥∥ · ∥∥W(1,α)â(1) +W(2,α)â(2)∥∥
for ϕαβ.
2.3 Asymptotic bias and correction
We first investigate Gαβ and Gαη when all of the p candidate SNPs are used, or when
cα = cβ = 0. Thus, â(1) = α̂(1), â(2) = α̂(2), b̂(1) = β̂(1), and b̂(2) = β̂(2). Then, we
have
Gαη =
(
W(1)η(1) + η
)T
WXT
(
X(1)α(1) + α
)∥∥W(1)η(1) + η∥∥ · ∥∥(X(1)α(1) + α)TXW T∥∥
and
Gαβ =
(
Z(1)β(1) + β
)T
ZW TWXT
(
X(1)α(1) + α
)∥∥(Z(1)β(1) + β)TZW T∥∥ · ∥∥(X(1)α(1) + α)TXW T∥∥ .
We have the following results on the asymptotic properties of Gαη, whose proof can be
found in the Appendix A.
Theorem 1. Under polygenic model (4) and Conditions 1 and 2, suppose mαη,mα,
and mη →∞ as min(n1, n3, p)→∞, and let p = c · (n1n3)a for some constants c > 0
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and a ∈ (0,∞]. If a ∈ (0, 1), then we have
Gαη = ϕαη +
(√
n1
n1 + p/h2α
· hη − 1
)
· ϕαη · {1 + op(1)}. (5)
If a ∈ [1,∞], then we have
Gαη · n3 = Op(1). (6)
Remark 2. For a ∈ (0, 1), Gαη is a biased estimator of ϕαη since
√
n1/(n1 + p/h2α) ·hη
is smaller than 1. Interestingly, the asymptotic bias is independent of the unknown
numbers mα,mη, and mαη, and is only determined by n1, p, h
2
α and h
2
η. When n1 and
p are comparable, a consistent estimator of ϕαη is given by
GAαη = Gαη ·
√
n1 + p/h2α
n1 · h2η
= ϕαη · {1 + op(1)}.
In addition, the testing sample size n3 vanishes in Gαη for a ∈ (0, 1), which verifies
that given the sample size n1 of discovery GWAS is large, we can apply the summary
statistics onto a much smaller set of target samples.
If a ∈ [1,∞], i.e., p/(n1n3) is too large, then Gαη will have a zero asymptotic limit.
In practice, this occurs when the sample size of discovery GWAS is too small to obtain
reliable GWAS summary statistics. When these summary statistics are applied on an
independent target dataset, the mean of genetic covariance yTη Ŝα cannot dominate its
standard error. The genetic variance ŜTα Ŝα is so overwhelming that Gαη goes to zero.
Details can be found in Appendix A.
The asymptotic properties of Gαβ are given as follows.
Theorem 2. Under polygenic model (4) and Conditions 1 and 2, suppose mαβ,mα,
and mβ →∞ as min(n1, n2, n3, p)→∞, and let p2 = c · (n1n2n3)a for some constants
c > 0 and a ∈ (0,∞]. If a ∈ (0, 1), then we have
Gαβ = ϕαβ +
(√
n1
n1 + p/h2α
· n2
n2 + p/h2β
− 1
)
· ϕαβ · {1 + op(1)}.
If a ∈ [1,∞], then we have
Gαβ · n3(n1 + p)(n2 + p)
p2
= Op(1).
Remark 3. For a ∈ (0, 1), Gαβ is a biased estimator of ϕαβ since
√
n1/(n1 + p/h2α) and√
n2/(n2 + p/h2β) are smaller than 1. The asymptotic bias is independent of mα,mβ,
and mαβ, and is determined by n1, n2, p, h
2
α and h
2
β. Giving that n1, n2, and p are
10
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Fig. 2: Raw genetic correlations estimated by cross-trait PRS with all
SNPs (left panels, A: Gαη, C: Gαβ) and the bias-corrected genetic correla-
tion estimates (right panels, B: GAαη, D: G
A
αβ). We set h
2
α = h
2
β = h
2
η = 1,
n1 = n2 = n3 = p = 10, 000, and m = 2000.
comparable, a consistent estimator of ϕαβ is given by
GAαβ = Gαβ ·
√
(n1 + p/h2α) · (n2 + p/h2β)
n1n2
= ϕαβ · {1 + op(1)}.
Now we propose a novel estimator of ϕαβ that can be directly constructed by using
two sets of summary statistics α̂ and β̂. Let
ϕ̂αβ =
α̂T β̂∥∥α̂∥∥ · ∥∥β̂∥∥ =
(
X(1)α(1) + α
)T
XZT
(
Z(1)β(1) + β
)∥∥(X(1)α(1) + α)TX∥∥ · ∥∥(Z(1)β(1) + β)TZ∥∥ ,
we have the following asymptotic properties.
Theorem 3. Under polygenic model (4) and Conditions 1 and 2, suppose mαβ,mα,
and mβ →∞ as min(n1, n2, p)→∞, and let p = c · (n1n2)a for some constants c > 0
and a ∈ (0,∞]. If a ∈ (0, 1), then we have
ϕ̂αβ = ϕαβ +
(√
n1
n1 + p/h2α
· n2
n2 + p/h2β
− 1
)
· ϕαβ · {1 + op(1)}.
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If a ∈ [1,∞], then we have
ϕ̂αβ · (n1 + p)(n2 + p)
p
= Op(1).
It follows from Theorem 3 that a consistent estimator of ϕαβ is given by
ϕ̂Aαβ = ϕ̂αβ ·
√
(n1 + p/h2α) · (n2 + p/h2β)
n1n2
= ϕαβ · {1 + op(1)}.
Since ϕ̂αβ and Gαβ have similar asymptotic properties, in what follows we will focus
on Gαβ and the general conclusions of Gαβ remain the same for ϕ̂αβ.
3 SNP screening
As shown in Theorems 1 and 2, in addition to heritability, the asymptotic bias of Gαη
or Gαβ is largely affected by n/p. These results intuitively suggest to select a subset of
p SNPs to construct cross-trait PRS. The common approach in practice is to screen the
SNPs according to their GWAS p-values. We investigate this strategy in this section.
For a given threshold cα > 0, let qα = p·piα = qα1+qα2 (piα ∈ (0, 1]) be the number of
top-ranked SNPs selected for yα, among which there are qα1 true causal SNPs and the
remaining qα2 are null SNPs, and we let qαη be the number of overlapping causal SNPs
of yα and yη. Similarly, given a threshold cβ > 0, let qβ = p·piβ = qβ1+qβ2 (piβ ∈ (0, 1])
be the number of top-ranked SNPs selected for yβ, among which there are qβ1 true
causal SNPs and the remaining qβ2 are null SNPs, and we let qαβ be the number of
overlapping causal SNPs of yα and yβ. Thus, qα1 ≥ qαη and min(qβ1, qα1) ≥ qαβ.
The SNP data are defined accordingly. We write X(1) = [X(11),X(12)], X(2) =
[X(21),X(22)], Z(1) = [Z(11),Z(12)], Z(2) = [Z(21),Z(22)], W(1,α) = [W(11,α),W(12,α)],
W(2,α) = [W(21,α),W(22,α)],W(1,β) = [W(11,β),W(12,β)], andW(2,β) = [W(21,β),W(22,β)].
Here X(11) and W(11,α) are the selected qα1 causal SNPs of yα, and Z(11) and W(11,β)
are the selected qβ1 causal SNPs of yβ. Similarly, X(21) and W(21,α) are the selected
qα2 null SNPs of yα, and Z(21) and W(21,β) are the selected qβ2 null SNPs of yβ. In
addition, we let α̂(1) = [α̂(11), α̂(12)], α̂(2) = [α̂(21), α̂(22)], β̂(1) = [β̂(11), β̂(12)], and
β̂(2) = [β̂(21), β̂(22)], where α̂(11) and β̂(11) correspond to the selected causal SNPs of
yα and yβ, respectively, and α̂(21) and β̂(21) correspond to the selected null ones. Then
we have
GTαη =
(
W(1)η(1) + η
)T (
W(11,α)α̂(11) +W(21,α)α̂(21)
)∥∥W(1)η(1) + η∥∥ · ∥∥W(11,α)α̂(11) +W(21,α)α̂(21)∥∥ = CTαηVη · VTα
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Fig. 3: Raw genetic correlation GTαη estimated by cross-trait PRS with
selected SNPs under different sparsity m/p and sample size n. We set
h2α = h
2
η = 1, ϕαη = 0.8, p = 10, 000, and n = 10, 000 (upper panels) or
2000 (lower panels).
where Vη =
∥∥W(1)η(1) + η∥∥,
VTα =
∥∥W(11,α)XT(11)(X(1)α(1) + α)+W(21,α)XT(21)(X(1)α(1) + α)∥∥, and
CTαη =
(
W(1)η(1) + η
)T
W(11,α)X
T
(11)
(
X(1)α(1) + α
)
+(
W(1)η(1) + η
)T
W(21,α)X
T
(21)
(
X(1)α(1) + α
)
.
Corollary 1. Under polygenic model (4) and Conditions 1 and 2, suppose that
min(mαη, mα, mη) → ∞ and min(qαη, qα1, qα2) → ∞ as min(n1, n3, p) → ∞, fur-
ther if
{
m2αη(qα1 + qα2)
}
/(q2αηn1n3) → 0, then we have
GTαη = ϕαη +
(√
n1mα
n1qα1 +mαqα/h2α
· qαη
mαη
· hη − 1
)
· ϕαη · {1 + op(1)}.
Corollary 1 shows the trade-off of SNP screening. Given n1, mα, mαη, hα, and hη,
the bias of GTαη is also affected by qα, qα1 and qαη. As more SNPs are selected, the
numerator of
√
(n1mα)/(n1qα1 +mαqα/h2α) · (qαη/mαη) increases with qαη, while the
denominator increases with
√
qα (and
√
qα1). Therefore, whether or not SNP screening
can improve the estimation is largely affected by the quality of the selected SNPs, which
is highly related to the properties of the GWAS summary statistics. In the optimistic
13
case where qαη = mαη and qα = qα1 = mα, GTαη becomes√
n1
n1 +mα/h2α
· hη · ϕαη,
which is the theoretical upper limit. We note that this optimistic upper limit is still
biased towards zero. Another interesting case is that the GWAS summary statistics of
causal and null SNPs are totally mixed up, which may occur when n1 = o(mα) (i.e.,
sample size is small or trait is highly polygenic/omnigenic) according to (3). Therefore,
we have qα1/qα ≈ mα/p. Suppose also qαη/qα1 ≈ mαη/mα, we have
GTαη ≈
√
n1
n1p+ p2/h2α
· qα · hη · ϕαη,
which increases with qα.
As qα = p, GTαη reaches its upper bound√
n1
n1 + p/h2α
· hη · ϕαη.
That is, GTαη achieves the best performance when the cross-trait PRS is constructed
without SNP screening. For example, in the left two panels of Figure 3, we set m/p =
0.01 to reflect the sparse signal case, in which causal and null SNPs can be easily
separated by SNP screening. Thus, SNP screening can reduce the bias of Gαη when
signals are sparse. However, as the number of causal SNPs increase (from left to right
in Figure 3), it becomes much hard to separate causal and null SNPs by their GWAS
p-values. Therefore, SNP screening will enlarge the bias.
Similarly, we have
GTαβ =
(
W(11,β)β̂(11) +W(21,β)β̂(21)
)T (
W(11,α)α̂(11) +W(21,α)α̂(21)
)
‖W(11,β)β̂(11) +W(21,β)β̂(21)‖ · ‖W(11,α)α̂(11) +W(21,α)α̂(21)‖
=
CTαβ
VTα · VTβ ,
where
CTαβ =
{
W(11,β)Z
T
(11)
(
Z(1)β(1) + β
)
+W(21,β)Z
T
(21)
(
Z(1)β(1) + β
)}T{
W(11,α)X
T
(11)
(
X(1)α(1) + α
)
+W(21,α)X
T
(21)
(
X(1)α(1) + α
)}
and VTβ =
∥∥W(11,β)ZT(11)(Z(1)β(1) + β)+W(21,β)ZT(21)(Z(1)β(1) + β)∥∥.
Corollary 2. Under polygenic model (4) and Conditions 1 and 2, suppose that
min(mαβ, mα, mβ) → ∞ and min(qαβ, qα1, qα2, qβ1, qβ2) → ∞ as min(n1, n2, n3, p) →
∞. Further if {m2αβ(qα1 + qα2)(qβ1 + qβ2)}/(q2αβn1n2n3)→ 0, then we have
Gαβ = ϕαβ +
(√
n1mα
n1qα1 +mαqα/h2α
· n2mβ
n2qβ1 +mβqβ/h
2
β
· qαβ
mαβ
− 1
)
· ϕαβ · {1 + op(1)}.
Corollary 2 shows the trade-off of SNP screening for Gαβ. Given n1, n2, mα, mβ,
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mαβ, hα, and hβ, the bias of GTαη is also affected by qα, qα1, qβ, qβ1 and qαβ. As more
SNPs are selected, the numerator of qαβ/mαβ increases with qαβ, while the denominator
of
√
(n1mα)/(n1qα1 +mαqα/h2α) · (n2mβ)/(n2qβ1 +mβqβ/h2β) increases with
√
qα and√
qβ (also
√
qα1 and
√
qβ1). In the optimistic case where qαβ = mαβ, qα = qα1 = mα
and qβ = qβ1 = mβ, GTαβ reduces to√
n1
n1 +mα/h2α
· n2
n2 +mβ/h
2
β
· ϕαβ,
which is the theoretical upper limit. On the other hand, suppose qαβ/qα1 ≈ mαβ/mα
and qαβ/qβ1 ≈ mαβ/mβ, when n1 = o(mα), n2 = o(mβ), i.e., the causal SNPs and null
SNPs are totally mixed, we have qα1/qα ≈ mα/p, qβ1/qβ ≈ mβ/p, and
GTαβ ≈
√
n1
n1p+ p2/h2α
· n2
n2p+ p2/h2α
· qαqβ · ϕαβ,
which increases with qα and qβ. Therefore, as qα = qβ = p, GTαβ reaches its upper
bound √
n1
n1 + p/h2α
· n2
n2 + p/h2β
· ϕαβ.
In conclusion, when causal SNP and null SNP can be easily separated by GWAS,
the top-ranked SNPs are more likely to be causal ones, that is, SNP screening helps.
However, for highly polygenic complex traits whose m/n is large, SNP screening may
result in larger bias and should be used with caution.
4 Overlapping samples
In real data applications, different GWAS may share a subset of participants. It is
often inconvenient to recalculate the GWAS summary statistics after removing the
overlapping samples. In this section, we examine the effect of overlapping samples on
the bias of cross-trait PRS, which provides more insights into the bias phenomenon of
cross-trait PRS. Particularly, we focus on two distinct cases which are both common in
practice: i) ns overlapping samples between discovery GWAS and Target testing data
for ϕαη estimation; and ii) ns overlapping samples between two discovery GWAS for
ϕαβ estimation.
Case i)
We add ns overlapping samples into Discovery GWAS-I and Target testing GWAS,
resulting in the following two new datasets:
• Dataset IV: (X,S,yα), with X ∈ Rn1×p, S ∈ Rns×p, and yTα = (yTαX ,yTαS ) ∈
R(n1+ns)×1.
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• Dataset V: (W ,S,yη), with W ∈ Rn3×p, S ∈ Rns×p, and yTη = (yTηW ,yTηS ) ∈
R(n3+ns)×1.
Mimicking h2, we define hαη ∈ (0, 1] as the proportion of phenotypic correlation that
can be explained by the correlation of their genetic components
hαη =
mαησαη
mαησαη + σαη
.
On the overlapping samples, we allow nonzero correlation between random errors to
capture the non-genetic contribution to phenotypic correlation. We introduce an ad-
ditional condition on random errors.
Condition 3. On ns overlapping samples, αj and ηj are independent random vari-
ables satisfying (
αj
ηj
)
∼ F
[(
0
0
)
,
(
σ2α σαη
σαη σ
2
η
)]
for j = 1, ..., ns, where σαη = ραη · σαση .
Theorem 4. Under polygenic model (4) and Conditions 1 - 3, suppose min(mαη, mα,
mη) → ∞ as min{(n1 + ns), (n3 + ns), p} → ∞, and let p = c · {(n1 + ns)(n3 + ns)}a
for some constants c > 0 and a ∈ (0,∞]. If a ∈ (0, 1), then GSαη can be written as[
1 + nsp/{(n1 + ns)(n3 + ns) · hαη}
] · [hη · ϕαη · {1 + op(1)}][
1 + p/{(n1 + ns) · h2α}+ 2nsp/{(n1 + ns)(n3 + ns)}+ nsp2/{(n1 + ns)2(n3 + ns) · h2α}
]1/2 .
If a ∈ [1,∞], then we have GSαη = op(1).
Remark 4. Theorem 4 shows the effect of ns overlapping samples on the estimation
of ϕαη. Both sample sizes (n1 +ns) and (n3 +ns) are involved in the bias. A consistent
estimator GASαη can be derived given that hαη is estimable. An interesting special case
is when the two GWAS are fully overlapped, then we have
GSαη =
ns + p/hαη{
n2s + 2nsp+ p(p+ ns)/h
2
α
}1/2 · hη · ϕαη · {1 + op(1)}.
In the optimal situation where h2α = h
2
η = hαη = 1, we have
GSαη =
(
1 +
1
p/ns + ns/p+ 2
)−1/2
· ϕαη · {1 + op(1)}.
Therefore, GSαη is asymptoticly biased unless either p = o(ns) or ns = o(p) holds,
neither of which is the case in modern GWAS. As ns and p are more comparable, the
asymptotic bias inGSαη increases and the largest bias occurs as p = ns →∞. Note that
it is not recommended to estimate the genetic correlation between two traits with (fully)
overlapping samples due to concerns such as confounding and overfitting [Dudbridge,
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Fig. 4: Raw genetic correlations estimated by cross-trait PRS with all
SNPs (left panels, A: GSαη, C: GSαβ) and bias-corrected genetic correlation
estimates (right panels, B: GASαη, D: G
A
Sαβ). We set h
2
α = h
2
β = h
2
η = 1,
n1 = ns = n2 = n3 = 5000 (half samples overlap), p = 10, 000, and
m = 2000.
2013, Pasaniuc and Price, 2017]. In our analysis, such concern is quantified by the value
of hαη. That is, when non-genetic correlation exists in error terms, we have hαη < 1,
and the estimation of genetic correlation is inflated. However, on the other hand, our
results show that even in an optimal overlapping setting with h2α = h
2
η = hαη = 1, the
cross-trait PRS estimator based on GWAS summary statistics is biased towards zero.
Case ii)
In this case, we add ns overlapping samples into Discovery GWAS-I and II, resulting
in the following two new datasets:
• Dataset IV: (X,S,yα), with X ∈ Rn1×p, S ∈ Rns×p, and yTα = (yTαX ,yTαS ) ∈
R(n1+ns)×1.
• Dataset VI: (Z,S,yβ), with Z ∈ Rn2×p, S ∈ Rns×p, and yTβ = (yTβZ ,yTβS ) ∈
R(n2+ns)×1.
Then we define hαβ ∈ (0, 1] as
hαβ =
mαβσαβ
mαβσαβ + σαβ
,
which quantifies the contribution of genetic correlation to the phenotypic correlation.
We introduce the following additional condition on random errors.
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Condition 4. On ns overlapping samples, αj and βj are independent random vari-
ables satisfying (
αj
βj
)
∼ F
[(
0
0
)
,
(
σ2α σαβ
σαβ σ
2
β
)]
for j = 1, ..., ns, where σαβ = ραβ · σασβ .
Theorem 5. Under polygenic model (4) and Conditions 1, 2 and 4, suppose min(mαβ,
mα, mβ)→∞ as min{(n1 +ns), (n2 +ns), n3, p} → ∞, and let p = c · {(n1 +ns)(n2 +
ns)n3}a for some constants c > 0 and a ∈ (0,∞]. If a ∈ (0, 1), then GSαβ is given by
(n1 + ns)
1/2(n2 + ns)
1/2 + nsp/{(n1 + ns)1/2(n2 + ns)1/2 · hαβ}{
(n1 + ns + p/h2α) · (n2 + ns + p/h2β)
}1/2 · ϕαβ · {1 + op(1)}.
If a ∈ [1,∞], then we have GSαβ = op(1).
Remark 5. Theorem 5 shows the effect of ns overlapping samples on the estimation of
ϕαβ. Since n3 vanishes in the bias, when (n1 +ns) and (n2 +ns) are large, a consistent
estimator GASαβ can be derived given that hαβ is estimable. When the two discovery
GWAS are fully overlapped, i.e., the two set of summary statistics are generated from
the same GWAS, then we have
GSαβ =
ns + p/hαβ{
(ns + p/h2α) · (ns + p/h2β)
}1/2 · ϕαβ · {1 + op(1)}.
In the optimal situation with h2α = h
2
β = hαβ = 1, we have GSαβ = ϕαβ · {1 + op(1)}.
Thus, GSαβ is a consistent estimator and we may have an unbiased estimator of genetic
correlation.
In summary, above analyses reveal that the bias in cross-trait PRS estimator may
result from the following facts: i) summary statistics are generated from independent
GWAS, where the induced bias is largely determined by the n/p ratio; ii) phenotypes
are not fully heritable, i.e., heritability is less than one; and iii) non-genetic correlation
exists in the random errors of overlapping samples. This may happen, for example,
when confounding effects are not fully adjusted. The first two facts may bias the ge-
netic correlation estimator towards zero, while the last fact may inflate the estimated
genetic correlation. In the supplementary file, we further investigate several other spe-
cific overlapping cases, which can be useful for quantifying potential bias and perform
correction in real data.
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5 Numerical experiments
5.1 GWAS of polygenic traits
We first numerically evaluate the marginal effect size estimates in GWAS with p =
100, 000 and n = 10, 000 or 1000. Each entry of X is independently generated from
N(0, 1). We vary the ratio m/p from 0.001 to 0.8 to reflect a wide range of sparsity.
The nonzero SNP effects in β(1) are independently generated from N(0, 1). Entries
of  are independently generated from N(0, 1). A continuous phenotype y is then
generated from model (1) and we apply model (2) to estimate the marginal effects. A
total of 200 replicates was conducted. We calculated the sum of the MSE of regression
coefficients β̂, the area under curve (AUC) and power of test statistics Ti (i = 1, · · · , p),
and enrichment, which is the proportion of true causal SNPs among the top (10%×p)-
ranked SNPs. As expected, when sparsity m/p increasing, the MSE of β̂ is inflated, and
both AUC and power of Tis decrease dramatically (Supplementary Figure 1). When
m/p is larger than 0.5, AUC is close to 0.5 and power is near zero. Enrichment is high
when m/p is small, but it drops dramatically as m/p increases. Finally, enrichment
becomes similar to m/p, reflecting that marginal screening can well preserve the rank
of variants only when signals are very sparse. These results indicate that causal and
null SNPs may be highly mixed in the ranking list of SNP for polygenic traits.
5.2 Cross-trait PRS with all SNPs
To illustrate the finite sample performance of our theoretical results, we simulate 10, 000
uncorrelated SNPs. The MAF of each SNP, f , is independently generated from Uni-
form [0.05, 0.45] based on which the SNP genotypes are independently sampled from
{0, 1, 2} with probabilities {(1−f)2, 2f(1−f), f2}, respectively. We set the same 2000
causal SNPs on each trait and the nonzero genetic effects are generated from Normal
distribution according to Condition 2 with σα = ση = σβ = 1. We set all heritability
to one and vary ϕαη and ϕαβ from 0.1 to 0.9. Model (4) is used to generate contin-
uous phenotypes. We generated 10, 000 samples in each dataset and a total of 200
replicates was conducted. Cross-trait PRS was built with all SNPs. We calculated
the raw estimators Gαη and Gαβ studied in Theorems 1 - 2, and the corresponding
bias-corrected estimators GAαη and G
A
αβ. The performance of Gαη and Gαβ is displayed
in the left panels of Figure 2. It is clear that these raw estimates are biased towards
zero. For example, when ϕαη = ϕαβ = 0.9, Gαη is around 0.6 while Gαβ is less than
0.45. The performance of GAαη and G
A
αβ is displayed in the right panels of Figure 2,
which indicates that the two bias-corrected estimators perform well and are close to
the true value of ϕαη and ϕαβ, respectively.
To verify that our results are independent of the signal sparsity, we set mα =
mβ = mη = p · aα and vary the sparsity aα = 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 0.6, 0.7
and 0.8 to generate sparse and dense signals. Next, we fix aα = 0.2 and set mβ =
mη = k ·mα to allow phenotypes to have different number of causal SNPs, where k =
0.3, 0.4, 0.5, 0.8, 1, 1.25, 2, 2.5 and 3.3. We set all heritability to one and let ϕαη = ϕαβ =
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0.5. Sample size is set to either 2000 or 10, 000. The performance of Gαη is displayed
in the upper panels of Supplementary Figure 2. The bias of Gαη is independent of
the sparsity aα of a trait or the ratio of sparsity k between two traits, which verifies
our results of Theorem 1. The bottom panels of Supplementary Figure 2 display the
performance of GAαη. It is clear that G
A
αη is unbiased regardless of aα and k. The
Supplementary Figure 3 shows a similar pattern in GAαη as heritability h
2
α = h
2
η = 0.5.
The performance of Gαβ and G
A
αβ is displayed in Supplementary Figure 4 and supports
our results in Theorem 2. Finally, we illustrate the performance of ϕ̂αβ and ϕ̂
A
αβ in
Supplementary Figure 5, verifying our results in Theorem 3 and the unbiasedness of
ϕ̂Aαβ.
5.3 SNP screening and overlapping samples
Instead of using all the 10, 000 SNPs, we construct cross-trait PRS with the top-ranked
SNPs whose GWAS p-values pass a pre-specified threshold. We consider a series of
thresholds {1, 0.8, 0.5, 0.4, 0.3, 0.2, 0.1, 0.08, 0.05, 0.02, 0.01, 10−3, 10−4, 10−5, 10−6,
10−7, 10−8} and generate a series of GTαη accordingly. We set heritability to one and
ϕαη = 0.8. Four levels of sparsity mα/p = mη/p = 0.01, 0.1, 0.5 and 0.8 are examined.
Figure 3 displays the performance of GTαη across a series of thresholds. As expected,
the pattern of GTαη varies dramatically with the sparsity. When signals are sparse,
SNP screening helps and GTαη performs better than Gαη. However, when signals are
dense, the performance of GTαη drops as the threshold decreases. GTαη has the best
performance as all SNPs are selected, i.e., the same as Gαη, which confirms our results
of GTαη in Corollary 1. In addition, we examine our analyses of overlapping samples.
For GSαη and GSαβ, half of the 10, 000 samples are set to be overlapping. Other
settings remain the same as those of Figure 2. The performance of GSαη, GSαβ, G
A
Sαη
and GASαβ is displayed in Figure 4, which fully support the results in Theorems 4 - 5.
6 UK Biobank data analysis
We apply our bias-corrected estimator on the United Kingdom (UK) Biobank data
[Sudlow et al., 2015] to assess the genetic correlation between brain white matter (WM)
tracts and several neuropsychiatric disorders. The structural changes of WM tracts
are measured and quantified in diffusion tensor imaging (dMRI). We run the TBSS-
ENIGMA pipeline [Thompson et al., 2014] to generate tract-based diffusion tensor
imaging (DTI) parameters from dMRI of UK Biobank samples. Seven DTI parameters,
FA, MD, MO, RD, L1, L2, and L3 (Supplementary Table 1) are derived in each of
the 18 WM tracts (Supplementary Table 2, Supplementary Figure 6), thus there are
7 × 18 = 126 DTI parameters in total. We use the unimputed UK Biobank SNP
data released in July 2017. Detailed genetic data collection/processing procedures and
quality control prior to the release of data are documented at http://www.ukbiobank.
ac.uk/scientists-3/genetic-data/. We take all autosomal SNPs and apply the
standard quality control procedures using the Plink tool set [Purcell et al., 2007]:
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excluding subjects with more than 10% missing genotypes, only including SNPs with
MAF > 0.01, genotyping rate > 90%, and passing Hardy-Weinberg test (P > 1×10−7).
The number of SNPs are 461, 488 after these steps. We further removed non-European
subjects if any. To avoid including closely related relatives, we excluded one of any pair
of individuals with estimated genetic relationship larger than 0.025. We then select
subjects that have DTI data as well, which yields a final dataset consisting of 7979
UK Biobank samples with age range [47, 80] (mean=64.26 years, sd=7.44), and the
proportion of female is 0.526.
Cross-trait PRSs of three psychiatric disorders are constructed on these UK Biobank
samples by using their published GWAS summary statistics, including attention-deficit
/hyperactivity disorder (ADHD, sample size 55, 374), bipolar disorder (BD, 41, 653),
and Schizophrenia (SCZ, 65, 967). The original GWAS [Demontis et al., 2017, Ruderfer
et al., 2018] have no overlapping samples with the UK Biobank data used in this study.
The GWAS summary data of these disorders are downloaded from the Psychiatric
Genomics Consortium [Sullivan et al., 2017]. To obtain independent SNPs, we perform
LD pruning with R2 = 0.2 and window size 50. There are 230, 072 SNPs remain after
LD pruning and they are used in later steps as candidates for constructing PRS. We
generate one PRS separately for each disorder by summarizing across all the pruned
candidates SNPs, weighed by their GWAS effect sizes (log odds ratios). The number of
overlapping SNPs is 204, 367 for SCZ, 215, 655 for BD, and 129, 052 for ADHD. Plink
tool set [Purcell et al., 2007] is used to generate these scores. The association between
each pair of PRS and DTI parameter is estimated and tested in linear regression,
adjusting for age, sex and ten genetic principal components of the UK Biobank. There
are 7× 18× 3 = 378 tests and we correct for multiple testing using the false discovery
rate (FDR) method [Storey, 2002] at 0.05 level.
We focus on the 20 significant associations after controlling for FDR: 17 for ADHD,
1 for BD, and 2 for SCZ (Supplementary Figure 7, Supplementary Table 3). On these
significant DTI-Disorder pairs, the proportions of variation in DTI parameter that can
be explained by PRS of disorder (partial R2) are all less than 0.2% (mean=0.125%,
max=0.197%, left panel of Figure 5). Partial R2 is the square of the estimated genetic
correlation between PRS and WM tract DTI parameters after adjusting for other
covariates and is often interpreted as the genetic overlap or shared genetic etiology
between the two traits. Such small R2s are widely reported in similar studies for
highly heritable psychiatric disorders [Bogdan et al., 2018, Clarke et al., 2016, Guo
et al., 2017a, Mistry et al., 2018, Power et al., 2015].
Next, we correct these estimates with our formula in Theorem 1. We applied the
heritability estimates of psychiatric disorders reported in a recent large-scale study
[Anttila et al., 2018]: 0.256 for SCZ, 0.205 for BD, and 0.100 for ADHD. We estimate
heritability of the 126 DTI parameters with the individual-level UK Biobank data using
the GCTA tool set [Yang et al., 2011]. These heritability estimates range from 0.224 to
0.733 with mean=0.532 and sd=0.087, and are reported in Zhao et al. [2018]. Plugging
in these heritability estimates, sample sizes and number of SNPs, the updated partial
R2s are much larger than previous ones (mean=5.260%, max=7.270%, right panel of
21
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Fig. 5: Raw partial R2 of fitting psychiatric disorder PRS on 18 brain
WM tracts (listed in x axis) in the UK Biobank data (left panel) and
corrected ones based on our formulas (right panel). Each tract has seven
DTI parameters (FA, MD, MO, RD, L1, L2, L3). Partial R2 measures the
variance in DTI parameter that can be explained by the PRS, adjusting
for age, sex and ten genetic principal components of the UK Biobank.
Figure 5). These corrected partial R2s are within 4% to 7.5% for ADHD, 2.5% to 3.5%
for SCZ, and is 4.8% for BD. In conclusion, we detect the significant association between
genetic risk scores of psychiatric disorders and brain WM microstructure changes in UK
Biobank participants sampled from the general population. Compared to the originally
estimated partial R2s, the corrected partial R2s may better reflect the degree of genetic
similarity between the two set of traits and suggest the potential prediction power of
brain imaging markers on these disorders.
7 Discussion
Understanding the genetic similarity among human complex traits is essential to model
biological mechanisms, improve genetic risk prediction, and design personalized pre-
vention/treatment. Cross-trait PRS [Power et al., 2015, Purcell et al., 2009] is one of
the most popular methods for genetic correlation estimation with thousands of pub-
lications. This paper empirically and theoretically studies the asymptotic properties
of cross-trait PRS. Our analyses demystify the commonly observed small R2 in real
data applications, and help avoid over- or under-interpreting of research findings. More
importantly, the asymptotic bias is largely independent of the unknown genetic archi-
tecture if we use all SNPs in cross-trait PRS, which enables bias correction. As the
sample size of discovery GWAS becomes much larger in the last few years [Evangelou
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et al., 2018, Lee et al., 2018] and may keep on increasing in the future, our bias-corrected
estimators can be used to recover the underlying genetic correlation of many complex
traits. We also discuss the popular SNP screening strategy and illustrate that this
procedure may enlarge the bias for highly polygenic traits, and thus should be used
with caution. Influence of overlapping samples is also quantified in several practical
cases.
The training-testing design employed by cross-trait PRS may help avoid the in-
flation caused by non-genetic correlation, but results in systematic bias due to the
restricted prediction power of GWAS summary statistics in testing data. The be-
havior of cross-trait PRS studied in this paper is closely related to the properties of
GWAS summary statistics, which have received little scrutiny in statistical genetics.
Our research should bring attentions to the potential unexpected results when analyz-
ing summary-level data of different GWAS for polygenic traits, and call to thoroughly
(re)study the statistical properties of other popular GWAS summary statistics-based
methods.
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Appendix A: Proofs
In this appendix, we highlight the key steps and results to prove our main theorems.
More proofs and technical details can be found in the supplementary file.
Proposition A1. Under polygenic model (4) and Conditions 1 and 2, if mαη,mα, and
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mη →∞ as min(n1, n3, p)→∞, then we have(
W(1)η(1) + η
)T (
W(1)η(1) + η
)
n3mη · σ2η + n3 · σ2η
= 1 + op(1),(
X(1)α(1) + α
)T
XW TWXT
(
X(1)α(1) + α
)
{n1n3mα(p−mα) + n1n3mα(mα + n1)} · σ2α + n1n3p · σ2α
= 1 + op(1).
Further if p/(n1n3)→ 0, then we have(
W(1)η(1) + η
)T
WXT
(
X(1)α(1) + α
)
n1n3mαη · σαη = 1 + op(1).
By continuous mapping theorem, we have
Gαη =
√
n1
n1 + p/h2α
· hη · ϕαη · {1 + op(1)}.
Then Theorem 1 holds for a ∈ (0, 1). When a ∈ [1,∞], i.e., p/(n1n3) 6→ 0, we note(
W(1)η(1) + η
)T
WXT
(
X(1)α(1) + α
)
= Op
{
(n
1/2
1 n
1/2
3 mαηp
1/2 + n1n3mαη) · σαη
}
.
It follows that
G2αη =
Op
{
(n1n3m
2
αηp+ n
2
1n
2
3m
2
αη) · σ2αη
}[
n3mη · σ2η · {1 + o(1)}
] · [n1n3mα(n1 + p) · σ2α · {1 + o(1)}]
= Op
{
n1n3p+ n
2
1n
2
3
n23n1(n1 + p)
· ϕ2αη
}
= Op(
1
n3
).
Thus, Theorem 1 is proved.
Proposition A2. Under polygenic model (4) and Conditions 1 and 2, if mαβ,mα, and
mβ →∞ as min(n1, n2, n3, p)→∞, then we have(
Z(1)β(1) + β
)T
ZW TWZT
(
Z(1)β(1) + β
)
{n2n3mβ(p−mβ) + n2n3mβ(mβ + n2)} · σ2β + n2n3p · σ2β
= 1 + op(1).
Further if p2/(n1n2n3)→ 0, then we have(
Z(1)β(1) + β
)T
ZW TWXT
(
X(1)α(1) + α
)
n1n2n3mαβ · σαβ = 1 + op(1).
It follows that Theorem 2 holds for a ∈ (0, 1). When a ∈ [1,∞], we have
G2αβ =
Op
{
(n1n2n3m
2
αβp
2 + n21n
2
2n
2
3m
2
αβ) · σαβ
}[
n2n3mβ(n2 + p) · σ2β · {1 + o(1)}
] · [n1n3mα(n1 + p) · σ2α · {1 + o(1)}]
= Op
{
n1n2n3p
2 + n21n
2
2n
2
3
n23n1n2(n1 + p)(n2 + p)
}
= Op
{ p2
n3(n1 + p)(n2 + p)
}
.
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Thus, Theorem 2 is proved.
Proposition A3. Under polygenic model (4) and Conditions 1 and 2, if mαβ,mα, and
mβ →∞ as min(n1, n2, p)→∞, then we have(
X(1)α(1) + α
)T
XXT
(
X(1)α(1) + α
)
{n1mα(n1 +mα) + n1mα(p−mα)} · σ2α + n1p · σ2α
= 1 + op(1),(
Z(1)β(1) + β
)T
ZZT
(
Z(1)β(1) + β
){
n2mβ(n2 +mβ) + n2mβ(p−mβ)
} · σ2β + n2p · σ2β = 1 + op(1).
Further if p/(n1n2)→ 0, then we have(
X(1)α(1) + α
)T
XZT
(
Z(1)β(1) + β
)
n1n2mαβ · σαβ = 1 + op(1).
Therefore Theorem 3 holds for a ∈ (0, 1). When a ∈ [1,∞], we have
ϕ̂2αβ =
Op
{
(n1n2m
2
αβp+ n
2
1n
2
2m
2
αβ) · σαβ
}[
n2mβ(n2 + p) · σ2β · {1 + o(1)}
] · [n1mα(n1 + p) · σ2α · {1 + o(1)}]
= Op
{
n1n2p+ n
2
1n
2
2
n1n2(n1 + p)(n2 + p)
}
= Op
{ p
(n1 + p)(n2 + p)
}
.
Thus, Theorem 3 is proved. Corollaries 1 and 2 follow from the two propositions below.
The proofs of overlapping samples can be found in the supplementary file.
Proposition A4. Under polygenic model (4) and Conditions 1 and 2, if min(mαη,mα,
mη)→∞, min(qαη, qα1, qα2)→∞ when min(n1, n3, p)→∞, then we have
VTα
{n1n3mαqα2 + n1n3qα1(mα + n1)} · σ2α + n1n3qα · σ2α
= 1 + op(1).
Further if {m2αη(qα1 + qα2)}/(q2αηn1n3)→ 0, then we have
CTαη
n1n3qαη · σαη = 1 + op(1).
Proposition A5. Under polygenic model (4) and Conditions 1 and 2, if min(mαβ,mα,
mβ)→∞, min(qαβ, qα1, qα2, qβ1, qβ2)→∞ when min(n1, n2, n3, p)→∞, then we have
VTβ
{n2n3mβqβ2 + n2n3qβ1(mβ + n2)} · σ2β + n1n3qβ · σ2β
= 1 + op(1).
Further if {m2αβ(qα1 + qα2)(qβ1 + qβ2)}/(q2αβn1n2n3)→ 0, then we have
CTαβ
n1n2n3qαβ · σαβ = 1 + op(1).
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Supplementary Material
8 More proofs
Proposition S1. Under polygenic model (4) and Conditions 1 - 3, suppose mαη,mα,
and mη →∞ as (n1 + ns), (n3 + ns), p→∞, then we have
yTη yη
(n3 + ns)mη · σ2η + (n3 + ns) · σ2η
= 1 + op(1) and
ŜTSαŜSα
vSα
= 1 + op(1),
where
yTη yη =
(
W(1,η)η(1) + ηw
)T (
W(1,η)η(1) + ηw
)
+
(
S(1,η)η(1) + ηs
)T (
S(1,η)η(1) + ηs
)
,
ŜTSαŜSα =
(
X(1,α)α(1) + αx
)T
XW TWXT
(
X(1,α)α(1) + αx
)
+
2
(
X(1,α)α(1) + αx
)T
XW TWST
(
S(1,α)α(1) + αs
)
+(
S(1,α)α(1) + αs
)T
SW TWST
(
S(1,α)α(1) + αs
)
+(
X(1,α)α(1) + αx
)T
XSTSXT
(
X(1,α)α(1) + αx
)
+
2
(
X(1,α)α(1) + αx
)T
XSTSST
(
S(1,α)α(1) + αs
)
+(
S(1,α)α(1) + αs
)T
SSTSST
(
S(1,α)α(1) + αs
)
,
and
vSα ={n1n3mα(p+ n1) · σ2α + n1n3p · σ2α}+ 2{n1n3nsmα · σ2α}+
{nsn3mα(p+ ns) · σ2α + nsn3p · σ2α}+ {n1nsmα(p+ n1) · σ2α + n1nsp · σ2α}
+ 2{n1nsmα(ns + p) · σ2α}+ {nsmα(n2s + p2 + 3nsp) · σ2α + nsp(ns + p) · σ2α}.
Further if p/{(n1 + nS)(n3 + ns)} → 0, then we have
yTη ŜSα
(n1 + ns)n3mαη · σαη + {nsmαη(p+ ns) · σαη + nsp · σαη}+ nsn1mαη · σαη
= 1 + op(1),
where yTη ŜSα is given by(
Tηw + η
T
(1)W
T
(1,η)
)
WXT
(
X(1,α)α(1) + αx
)
+
(
Tηw + η
T
(1)W
T
(1,η)
)
WST
(
S(1,α)α(1) + αs
)
+
(
Tηs + η
T
(1)S
T
(1,η)
)
SST
(
S(1,α)α(1) + αs
)
+
(
Tηs + η
T
(1)S
T
(1,η)
)
SXT
(
X(1,α)α(1) + αx
)
.
Proposition S2. Under polygenic model (4) and Conditions 1, 2 and 4, suppose
mαβ,mα, and mβ →∞ as (n1 + ns), (n2 + ns), n3, p→∞, then we have
ŜTSαŜSα
vSα
= 1 + op(1) and
ŜTSβŜSβ
vSβ
= 1 + op(1),
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where
ŜTSαŜSα =
(
X(1,α)α(1) + αx
)T
XW TWXT
(
X(1,α)α(1) + αx
)
+
2
(
X(1,α)α(1) + αx
)T
XW TWST
(
S(1,α)α(1) + αs
)
+(
S(1,α)α(1) + αs
)T
SW TWST
(
S(1,α)α(1) + αs
)
,
ŜTSβŜSβ =
(
Z(1,β)β(1) + βz
)T
ZW TWZT
(
Z(1,β)β(1) + βz
)
+
2
(
Z(1,β)β(1) + βz
)T
ZW TWST
(
S(1,β)β(1) + βs
)
+(
S(1,β)β(1) + βs
)T
SW TWST
(
S(1,β)β(1) + βs
)
,
vSα =n1n3mα(p+ n1) · σ2α + n1n3p · σ2α + 2n1n3nsmα · σ2α+
nsn3mα(p+ ns) · σ2α + nsn3p · σ2α ,
and
vSβ =n2n3mβ(p+ n2) · σ2β + n2n3p · σ2β + 2n2n3nsmβ · σ2β+
nsn3mβ(p+ ns) · σ2β + nsn3p · σ2β .
Further if p2/{(n1 + ns)(n2 + ns)n3} → 0, then we have
ŜTSαŜSβ
vSαβ
= 1 + op(1),
where
ŜTSαŜSβ =
(
X(1,α)α(1) + αx
)T
XW TWZT
(
Z(1,β)β(1) + βz
)
+(
X(1,α)α(1) + αx
)T
XW TWST
(
S(1,β)β(1) + βs
)
+(
S(1,α)α(1) + αs
)T
SW TWZT
(
Z(1,β)β(1) + βz
)
+(
S(1,α)α(1) + αs
)T
SW TWST
(
S(1,β)β(1) + βs
)
,
and
vSαβ =n1n2n3mαβ · σαβ + n1nsn3mαβ · σαβ + nsn2n3mαβ · σαβ+
{ns(p+ ns)n3mαβ · σαβ + nsn3p · σαβ}.
Then Theorems 4 and 5 follow from continuous mapping theorem and similar ar-
guments in the Appendix A.
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9 More overlapping cases
This section provides more analyses on the overlapping samples. We consider several
additional cases that might occur in real data applications.
Case iii)
When the two GWAS are fully overlapped, i.e., the two set of summary statistics α̂
and β̂ are generated from the same GWAS data
• Dataset VII: (X,yα,yβ), with X = [X(1,α),X(2,α)] = [X(1,β),X(2,β)] ∈ Rn1×p,
X(1,α) ∈ Rn1×mα , X(1,β) ∈ Rn1×mβ , yα ∈ Rn1×1, and yβ ∈ Rn1×1.
We assume that yα and yβ have polygenic architectures. We estimate ϕαβ directly by
estimating the correlation of α̂ and β̂
ϕ̂Xαβ =
α̂T β̂∥∥α̂∥∥ · ∥∥β̂∥∥
=
(
X(1,α)α(1) + α
)T
XXT
(
X(1,β)β(1) + β
){(
X(1,α)α(1) + α
)T
XXT
(
X(1,α)α(1) + α
)}1/2{(
X(1,β)β(1) + β
)T
XXT
(
X(1,β)β(1) + β
)}1/2 .
Proposition S3. Under polygenic models and Conditions 1, 2 and 4, if mαβ,mα, and
mβ →∞, as n1, p→∞, then we have(
X(1,α)α(1) + α
)T
XXT
(
X(1,α)α(1) + α
)
{n1mα(n1 +mα) + n1mα(p−mα)} · σ2α + n1p · σ2α
= 1 + op(1),(
X(1,β)β(1) + β
)T
XXT
(
X(1,β)β(1) + β
)
{n1mβ(n1 +mβ) + n1mβ(p−mβ)} · σ2β + n1p · σ2β
= 1 + op(1),
and (
X(1,α)α(1) + α
)T
XXT
(
X(1,β)β(1) + β
)
n1mαβ(p+ n1) · σαβ + n1p · σαβ
= 1 + op(1).
Thus, we have
ϕ̂Xαβ =
n1 + p/hαβ
(n1 + p/h2α)
1/2(n1 + p/h2β)
1/2
· ϕαβ · {1 + op(1)}.
It follows that ϕ̂Xαβ is asymptotically unbiased as h
2
α = h
2
β = hαβ = 1. Otherwise,
ϕ̂Xαβ may be biased towards zero.
Case iv)
Again, the two set of summary statistics α̂ and β̂ are generated from the same GWAS
dataset
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• Dataset VII: (X,yα,yβ), with X = [X(1,α),X(2,α)] = [X(1,β),X(2,β)] ∈ Rn1×p,
X(1,α) ∈ Rn1×mα , X(1,β) ∈ Rn1×mβ , yα ∈ Rn1×1, and yβ ∈ Rn1×1.
And we construct two PRSs ŜXα and ŜXβ on X.
Proposition S4. Under polygenic models and Conditions 1, 2 and 4, if mαβ,mα, and
mβ →∞, as n1, p→∞, then we have
ŜTXαŜXα
vXα
= 1 + op(1) and
ŜTXβŜXβ
vXβ
= 1 + op(1),
where
ŜTXαŜXα = (X(1,α)α(1) + α)
TXXTXXT (X(1,α)α(1) + α),
ŜTXβŜXβ = (X(1,β)β(1) + β)
TXXTXXT (X(1,β)β(1) + β),
vXα = n1mα{(n1 + p)2 + n1p} · σ2α + n1p(n1 + p) · σ2α , and
vXβ = n1mβ{(n1 + p)2 + n1p} · σ2β + n1p(n1 + p) · σ2β .
Similarly, we have
ŜTXβŜXα
vXαβ
= 1 + op(1),
where vXαβ = n1mαβ{(n1 + p)2 + n1p} · σαβ + n1p(n1 + p) · σαβ and
ŜTXβŜXα = (X(1,β)β(1) + β)
TXXTXXT (X(1,α)α(1) + α).
Thus, we have
GXαβ =
n21 + 2n1p+ p(n1 + p)/hαβ{
n21 + 2n1p+ p(n1 + p)/h
2
α
}1/2{
n21 + 2n1p+ p(n1 + p)/h
2
β
}1/2 · ϕαβ · {1 + op(1)}.
It follows that GXαβ is asymptotically unbiased if h
2
α = h
2
β = hαβ = 1. Otherwise,
GXαβ may be biased towards zero.
Case v)
The two set of GWAS summary statistics α̂ and β̂ are generated from the following
two independent datasets:
• Dataset VIII: (X,yα), with X = [X(1),X(2)] ∈ Rn1×p, X(1) ∈ Rn1×mα , and
yα ∈ Rn1×1.
• Dataset IX: (Z,yβ), with Z = [Z(1),Z(2)] ∈ Rn2×p, Z(1) ∈ Rn2×mβ , and yβ ∈
Rn2×1.
We construct two PRSs ŜXα and ŜXβ on X.
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Proposition S5. Under polygenic models and Conditions 1, 2 and 4, if mαβ,mα, and
mβ →∞, as n1, n2, p→∞, then we have
ŜTXαŜXα
vXα
= 1 + op(1) and
ŜTXβŜXβ
vXβ
= 1 + op(1),
where
ŜTXαŜXα =
(
X(1,α)α(1) + α
)T
XXTXXT
(
X(1,α)α(1) + α
)
,
ŜTXβŜXβ =
(
Z(1,β)β(1) + β
)T
ZXTXZT
(
Z(1,β)β(1) + β
)
,
vXα = n1mα{(n1 + p)2 + n1p} · σ2α + n1p(n1 + p) · σ2α , and
vXβ = n1n2mβ(p+ n2) · σ2β + n1n2p · σ2β .
Further if p/(n1n2)→ 0, then we have
ŜTXβŜXα
vXαβ
= 1 + op(1),
where vXαβ = n1n2mαβ(n1 + p) · σαβ and
ŜTXβŜXα =
(
X(1,α)α(1) + α
)T
XXTXZT
(
Z(1,β)β(1) + β
)
.
Let p = c · (n1n2)a for some constants c > 0 and a ∈ (0,∞]. As n1 and n2 increase to
∞, if a ∈ (0, 1), then we have
GXαβ =
(n1 + p) · n1/22{
n21 + 2n1p+ p(n1 + p)/h
2
α
}1/2{
n2 + p/h2β
}1/2 · ϕαβ · {1 + op(1)}.
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10 Intermediate results
Cross-trait PRS with all SNPs
Proposition S6. Under polygenic model (4) and Conditions 1 and 2, if mαη,mα, and
mη →∞ as n1, n3, p→∞, then we have
E
{(
W(1)η(1) + η
)T
WXT
(
X(1)α(1) + α
)}
= n1n3mαη · σαη,
Var
{(
W(1)η(1) + η
)T
WXT
(
X(1)α(1) + α
)}
= {(n1n3m2αηp+
2n21n3m
2
αη + 2n1n
2
3m
2
αη) · σ2αη + n21n23mαη · (a22 − σ2αη)} · {1 + o(1)},
E
{(
W(1)η(1) + η
)T (
W(1)η(1) + η
)}
= n3mη · σ2η + n3 · σ2η ,
Var
{(
W(1)η(1) + η
)T (
W(1)η(1) + η
)}
= o(n23m
2
η · σ4η),
E
{(
X(1)α(1) + α
)T
XW TWXT
(
X(1)α(1) + α
)}
=
[
n1n3mα(n1 +mα) · {1 + o(1)}+ n1n3mα(p−mα)
] · σ2α + n1n3p · σ2α ,
Var
{(
X(1)α(1) + α
)T
XW TWXT
(
X(1)α(1) + α
)}
= o{n21n23m2α(n1 + p)2 · σ4α},
where a22 = E(α
2η2) <∞.
Proposition S7. Under polygenic model (4) and Conditions 1 and 2, if mαβ,mα, and
mβ →∞ as n1, n2, n3, p→∞, then we have
E
{(
Z(1)β(1) + β
)T
ZW TWXT
(
X(1)α(1) + α
)}
= n1n2n3mαβ · σαβ,
Var
{(
Z(1)β(1) + β
)T
ZW TWXT
(
X(1)α(1) + α
)}
= O(n1n2n3m
2
αβp
2) + o(n21n
2
2n
2
3m
2
αβ),
E
{(
Z(1)β(1) + β
)T
ZW TWZT
(
Z(1)β(1) + β
)}
=
[
n2n3mβ(n2 +mβ) · {1 + o(1)}+ n2n3mβ(p−mβ)
] · σ2β + n2n3p · σ2β ,
Var
{(
Z(1)β(1) + β
)T
ZW TWZT
(
Z(1)β(1) + β
)}
= o{n22n23m2β(n2 + p)2 · σ4β}.
Proposition S8. Under polygenic model (4) and Conditions 1 and 2, if mαβ,mα, and
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mβ →∞ as n1, n2, p→∞, then we have
E
{(
Z(1)β(1) + β
)T
ZXT
(
X(1)α(1) + α
)}
= n1n2mαβ · σαβ,
Var
{(
Z(1)β(1) + β
)T
ZXT
(
X(1)α(1) + α
)}
= O(n1n2m
2
αβp) + o(n
2
1n
2
2m
2
αβ),
E
{(
X(1)α(1) + α
)T
XXT
(
X(1)α(1) + α
)}
=
[
n1mα(n1 +mα) · {1 + o(1)}+ n1mα(p−mα)
] · σ2α + n1p · σ2α ,
Var
{(
X(1)α(1) + α
)T
XXT
(
X(1)α(1) + α
)}
= o{n21m2α(n1 + p)2 · σ4α},
E
{(
Z(1)β(1) + β
)T
ZZT
(
Z(1)β(1) + β
)}
=
[
n2mβ(n2 +mβ) · {1 + o(1)}+ n2mβ(p−mβ)
] · σ2β + n2p · σ2β ,
Var
{(
Z(1)β(1) + β
)T
ZZT
(
Z(1)β(1) + β
)}
= o{n22m2β(n2 + p)2 · σ4β}.
Then Propositions A1 - A3 follow from Markov’s inequality.
Cross-trait PRS with selected SNPs
Proposition S9. Under polygenic model (4) and Conditions 1 and 2, suppose mαη,
mαβ, mα,mη, and mβ →∞, qαβ, qα1, qα2, qβ1, qβ2, and qαη →∞ as n1, n2, n3, p→∞,
then we have
E(Cαη) = n1n3qαη · σαη,
Var(Cαη) = O(m
2
αηn1n3qα) + o(n
2
1n
2
3q
2
αη),
E(Vα) = {n1n3mαqα2 + n1n3qα1(mα + n1)} · σ2α · {1 + o(1)}+ n1n3qα · σ2α ,
Var(Vα) = o
[{n1n3mαqα2 + n1n3qα1(mα + n1)}2],
E(Cαβ) = n1n2n3qαβ · σαβ,
Var(Cαη) = O(m
2
αβn1n2n3qαqβ) + o(n
2
1n
2
2n
2
3q
2
αβ),
E(Vβ) = {n2n3mβqβ2 + n2n3qβ1(mβ + n2)} · σ2β · {1 + o(1)}+ n2n3qα · σ2α ,
Var(Vα) = o
[{n2n3mβqβ2 + n2n3qβ1(mβ + n2)}2].
Then Propositions A4 and A5 follow from Markov’s inequality.
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Overlapping samples
Proposition S10. Under polygenic model (4) and Conditions 1 - 3, suppose mαη,mα,
and mη →∞ as (n1 + ns), (n3 + ns), p→∞, then we have
E
(
yTη ŜSα
)
= (n3 + ns)(n1 + ns)mαη · σαη + nsmαηp · σαη + nsp · σαη ,
Var
(
yTη ŜSα
)
= O
{
(n3 + ns)(n1 + ns)m
2
αηp
}
+ o
{
E2(yTη ŜSα)
}
,
E
(
yTη yη
)
= (n3 + ns)mη · σ2η + (n3 + ns) · σ2η ,
Var
(
yTη yη
)
= o
{
(n3 + ns)
2m2η · σ4η
}
,
E
(
ŜTSαŜSα
)
=
{
n1n3mα(p+ n1) · σ2α + n1n3p · σ2α
}
+ 2
{
n1n3nsmα · σ2α
}
+{
nsn3mα(p+ ns) · σ2α + nsn3p · σ2α
}
+
{
n1nsmα(p+ n1) · σ2α + n1nsp · σ2α
}
+ 2
{
n1nsmα(ns + p) · σ2α
}
+
{
nsmα(n
2
s + p
2 + 3nsp) · σ2α + nsp(ns + p) · σ2α
}
,
Var
(
ŜTSαŜSα
)
= o
{
E2(ŜTSαŜSα)
}
.
Proposition S11. Under polygenic model (4) and Conditions 1, 2 and 4, suppose
mαβ,mα, and mβ →∞ as (n1 + ns), (n2 + ns), n3, p→∞, then we have
E
(
ŜTSαŜSβ
)
= (n1 + ns)(n2 + ns)n3mαβ · σαβ + nsn3mαβp · σαβ + nsn3p · σαβ ,
Var
(
ŜTSαŜSβ
)
= O
{
(n1 + ns)(n2 + ns)n3m
2
αηp
2
}
+ o
{
E2(ŜTSαŜSβ)
}
,
E(ŜTSαŜSα) = n1n3mα(p+ n1) · σ2α + n1n3p · σ2α + 2n1n3nsmα · σ2α+
nsn3mα(p+ ns) · σ2α + nsn3p · σ2α ,
Var(ŜTSαŜSα) = o
{
E2(ŜTSαŜSα)
}
,
E(ŜTSβŜSβ) = n2n3mβ(p+ n2) · σ2β + n2n3p · σ2β + 2n2n3nsmβ · σ2β+
nsn3mβ(p+ ns) · σ2β + nsn3p · σ2β ,
Var(ŜTSβŜSβ) = o
{
E2(ŜTSβŜSβ)
}
.
Then Propositions S1 and S2 follow from Markov’s inequality.
11 Additional technical details
The following technical details are useful in proving our theoretical results. Most of
them involve in calculating the asymptotic expectation of the trace of the product of
multiple large random matrices.
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First moment of covariance term
E
{(
W(1)η(1) + η
)T
WXT
(
X(1)α(1) + α
)}
= E
{
tr(ηT(1)W
T
(1)WX
TX(1)α(1))
}
= n1n3mαη · σαη.
First moment of variance terms
E
{(
W(1)η(1) + η
)T (
W(1)η(1) + η
)}
= E
{
tr(W T(1)W(1))
} · σ2η + Tη η = n3mη · σ2η + n3 · σ2η .
E
{(
X(1)α(1) + α
)T
XW TWXT
(
X(1)α(1) + α
)}
= E
(
αT(1)X
T
(1)X(1)W
T
(1)W(1)X
T
(1)X(1)α(1)
)
+ E
(
αT(1)X
T
(1)X(2)W
T
(2)W(2)X
T
(2)X(1)α(1)
)
+ 2E
(
αT(1)X
T
(1)X(1)W
T
(1)W(2)X
T
(2)X(1)α(1)
)
+ E
(
TαXW
TWXT α
)
=
[
n1n3mα(n1 +mα) · {1 + o(1)}+ n1n3mα(p−mα)
] · σ2α + n1n3p · σ2α .
Second moment of covariance term
E
(
ηT(1)W
T
(1)WX
TX(1)α(1)η
T
(1)W
T
(1)WX
TX(1)α(1)
)
= E
(
tr(ηT(1)W
T
(1)W(1)X
T
(1)X(1)α(1)η
T
(1)W
T
(1)W(1)X
T
(1)X(1)α(1))
)
+ E
(
tr(ηT(1)W
T
(1)W(2)X
T
(2)X(1)α(1)η
T
(1)W
T
(1)W(2)X
T
(2)X(1)α(1))
)
+ 2E
(
tr(ηT(1)W
T
(1)W(1)X
T
(1)X(1)α(1)η
T
(1)W
T
(1)W(2)X
T
(2)X(1)α(1))
)
= (n21n
2
3m
2
αη + n1n3m
2
αηp+ 2n
2
1n3m
2
αη + 2n1n
2
3m
2
αη) · σ2αη + n21n23mαη · (a22 − σ2αη).
It follows that
Var
(
ηT(1)W
T
(1)WX
TX(1)α(1)
)
= n1n3m
2
αηp · σ2αη · {1 + o(1)}+ o(n21n23m2αη · σ2αη).
Second moment of variance terms
E
(
ηT(1)W
T
(1)W(1)η(1)η
T
(1)W
T
(1)W(1)η(1)
)
= n23m
2
η · σ4η + n3mη{2mησ4η + n3(b4 − σ4η) + c4b4 − 2σ4η − b4} = n23m2η · σ4η · {1 + o(1)}.
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and
E
(
αT(1)X
T
(1)XW
TWXTX(1)α(1)α
T
(1)X
T
(1)XW
TWXTX(1)α(1)
)
= E
(
αT(1)X
T
(1)X(1)W
T
(1)W(1)X
T
(1)X(1)α(1)α
T
(1)X
T
(1)X(1)W
T
(1)W(1)X
T
(1)X(1)α(1)
)
+ E
(
αT(1)X
T
(1)X(2)W
T
(2)W(2)X
T
(2)X(1)α(1)α
T
(1)X
T
(1)X(2)W
T
(2)W(2)X
T
(2)X(1)α(1)
)
+ 4E
(
αT(1)X
T
(1)X(1)W
T
(2)W(2)X
T
(1)X(1)α(1)α
T
(1)X
T
(1)X(1)W
T
(1)W(2)X
T
(2)X(1)α(1)
)
+ 2E
(
αT(1)X
T
(1)X(1)W
T
(1)W(1)X
T
(1)X(1)α(1)α
T
(1)X
T
(1)X(2)W
T
(2)W(2)X
T
(2)X(1)α(1)
)
= n21n
2
3m
2
α(n1 + p)
2 · σ4α · {1 + o(1)}.
Similarly, we have
E
(
βT(1)Z
T
(1)ZW
TWXTZ(1)β(1)β
T
(1)Z
T
(1)ZW
TWZTZ(1)β(1)
)
= n22n
2
3m
2
β(n2 + p)
2 · σ4β · {1 + o(1)}.
Thus, we have
Var
(
ηT(1)W
T
(1)W(1)η(1)
)
= o(n23m
2
η · σ4η),
Var
(
αT(1)X
T
(1)XW
TWXTX(1)α(1)
)
= o
{
n21n
2
3m
2
α(n1 + p)
2 · σ4α
}
,
Var
(
βT(1)Z
T
(1)ZW
TWXTZ(1)β(1)
)
= o
{
n22n
2
3m
2
β(n2 + p)
2 · σ4β
}
.
First moment of covariance term
E
{(
Z(1)β(1) + β
)T
ZW TWXT
(
X(1)α(1) + α
)}
= E
(
βT(1)Z
T
(1)ZW
TWXTX(1)α(1)
)
= E
(
tr(βT(1)Z
T
(1)Z(1)W
T
(1)W(1)X
T
(1)X(1)α(1))
)
= n1n2n3mαβ · σαβ.
Second moment of covariance term
E
(
βT(1)Z
T
(1)ZW
TWXTX(1)α(1)β
T
(1)Z
T
(1)ZW
TWXTX(1)α(1)
)
= E
(
βT(1)Z
T
(1)Z(1)W
T
(1)W(1)X
T
(1)X(1)α(1)β
T
(1)Z
T
(1)Z(1)W
T
(1)W(1)X
T
(1)X(1)α(1)
)
+ E
(
βT(1)Z
T
(1)Z(1)W
T
(1)W(2)X
T
(2)X(1)α(1)β
T
(1)Z
T
(1)Z(1)W
T
(1)W(2)X
T
(2)X(1)α(1)
)
+ E(βT(1)Z
T
(1)Z(2)W
T
(2)W(1)X
T
(1)X(1)α(1)β
T
(1)Z
T
(1)Z(2)W
T
(2)W(1)X
T
(1)X(1)α(1)
)
+ E
(
βT(1)Z
T
(1)Z(2)W
T
(2)W(2)X
T
(2)X(1)α(1)β
T
(1)Z
T
(1)Z(2)W
T
(2)W(2)X
T
(2)X(1)α(1)
)
= O
[
n1n2n3m
2
αβ{(p−mα)(p−mβ) + (p−mα)mβ +mα(p−mβ) +mαmα}
]
+ n21n
2
2n
2
3m
2
αβ · σ2αβ · {1 + o(1)}
= O(n1n2n3m
2
αβp
2) + n21n
2
2n
2
3m
2
αβ · σ2αβ · {1 + o(1)}.
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It follows that
Var
(
βT(1)Z
T
(1)ZW
TWXTX(1)α(1)
)
= O(n1n2n3m
2
αβp
2) + o(n21n
2
2n
2
3m
2
αβ · σ2αβ).
First moment of covariance term
E
{(
Z(1)β(1) + β
)T
ZXT
(
X(1)α(1) + α
)}
= E
(
tr(βT(1)Z
T
(1)ZX
TX(1)α(1))
)
= n1n2mαβ · σαβ.
First moment of variance terms
E
{(
X(1)α(1) + α
)T
XXT
(
X(1)α(1) + α
)}
= E
(
αT(1)X
T
(1)X(1)X
T
(1)X(1)α(1)
)
+ E
(
αT(1)X
T
(1)X(2)X
T
(2)X(1)α(1)
)
+ E
(
TαXX
T α
)
=
[
n1mα(n1 +mα) · {1 + o(1)}+ n1mα(p−mα)
] · σ2α + n1p · σ2α .
Similarly, we have
E
{(
Z(1)β(1) + β
)T
ZZT
(
Z(1)β(1) + β
)}
=
[
n2mβ(n2 +mβ) · {1 + o(1)}+ n2mβ(p−mβ)
] · σ2β + n2p · σ2β .
Second moment of covariance term
E
(
βT(1)Z
T
(1)ZX
TX(1)α(1)β
T
(1)Z
T
(1)ZX
TX(1)α(1)
)
= E
(
βT(1)Z
T
(1)Z(1)X
T
(1)X(1)α(1)β
T
(1)Z
T
(1)Z(1)X
T
(1)X(1)α(1)
)
+ E
(
βT(1)Z
T
(1)Z(1)X
T
(1)X(1)α(1)β
T
(1)Z
T
(1)Z(2)X
T
(2)X(1)α(1)
)
+ E
(
βT(1)Z
T
(1)Z(2)X
T
(2)X(1)α(1)β
T
(1)Z
T
(1)Z(1)X
T
(1)X(1)α(1)
)
+ E
(
βT(1)Z
T
(1)Z(2)X
T
(2)X(1)α(1)β
T
(1)Z
T
(1)Z(2)X
T
(2)X(1)α(1)
)
= O(n1n2m
2
αβp) + n
2
1n
2
2m
2
αβ · σ2αβ · {1 + o(1)}.
It follows that
Var
(
βT(1)Z
T
(1)ZX
TX(1)α(1)
)
= O(n1n2m
2
αβp) + o(n
2
1n
2
2m
2
αβ · σ2αβ).
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Second moment of variance terms
E
(
αT(1)X
T
(1)XX
TX(1)α(1)α
T
(1)X
T
(1)XX
TX(1)α(1)
)
= E
(
αT(1)X
T
(1)X(1)X
T
(1)X(1)α(1)α
T
(1)X
T
(1)X(1)X
T
(1)X(1)α(1)
)
+ E
(
αT(1)X
T
(1)X(2)X
T
(2)X(1)α(1)α
T
(1)X
T
(1)X(1)X
T
(1)X(1)α(1)
)
+ E
(
αT(1)X
T
(1)X(1)X
T
(1)X(1)α(1)α
T
(1)X
T
(1)X(2)X
T
(2)X(1)α(1)
)
+ E
(
αT(1)X
T
(1)X(2)X
T
(2)X(1)α(1)α
T
(1)X
T
(1)X(2)X
T
(2)X(1)α(1)
)
= n21m
2
α(p+ n1)
2 · σ4α · {1 + o(1)}.
Similarly, we have
E
(
βT(1)Z
T
(1)ZZ
TZ(1)β(1)β
T
(1)Z
T
(1)ZZ
TZ(1)β(1)
)
= n22m
2
β(p+ n2)
2 · σ4β · {1 + o(1)}.
Thus, we have
Var
(
αT(1)X
T
(1)XX
TX(1)α(1)
)
= o
{
n21m
2
α(p+ n1)
2 · σ4α
}
,
Var
(
βT(1)Z
T
(1)ZZ
TZ(1)β(1)
)
= o
{
n22m
2
β(p+ n2)
2 · σ4β
}
.
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Supplementary Fig. 1: Trends of GWAS performance when varying
sparsity m/p and sample size n: AUC of tests, power of tests, enrichment
of top-ranked SNP, and MSE of estimated genetic effects.
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Supplementary Fig. 2: Raw genetic correlations estimated by cross-
trait PRS with all SNPs (Gαη, upper panels) and corrected ones based
on our formulas (GAαη, bottom panels). We set h
2
α = h
2
η = 1, ϕαη = 0.5,
p = 10, 000, and vary mα, mη and n.
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Supplementary Fig. 3: Raw genetic correlations estimated by cross-
trait PRS with all SNPs (Gαη, upper panels) and corrected ones based on
our formulas (GAαη, bottom panels). We set h
2
α = h
2
η = 0.5, ϕαη = 0.5,
p = 10, 000, and vary mα, mη and n.
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Supplementary Fig. 4: Raw genetic correlations estimated by cross-
trait PRS with all SNPs (Gαβ, upper panels) and corrected ones based
on our formulas (GAαβ, bottom panels). We set h
2
α = h
2
β = 1, ϕαβ = 0.5,
p = 10, 000, and vary mα, mβ and n.
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Supplementary Fig. 5: Raw genetic correlations estimated by cross-
trait PRS directly with all SNPs (ϕ̂αβ, upper panels) and corrected ones
based on our formulas (ϕ̂Aαβ, bottom panels). We set h
2
α = h
2
β = 1, ϕαβ =
0.5, p = 10, 000, and vary mα, mβ and n.
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Supplementary Fig. 6: WM main tracts annotation. Originally pub-
lished in Zhao et al. [2018]. We examine 18 WM tracts in our real data
analysis, whose full names are listed in Supplementary Table 2.
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Supplementary Fig. 7: Associations between the PRS of four psychi-
atric disorders created from the published GWAS summary statistics, and
18 brain WM tracts in the UK Biobank dataset. We control for age, sex,
and 10 genetic principal components for population structure. FDR is con-
trolled at 0.05 level. SCZ, Schizophrenia; BD, Bipolar disorder; ADHD:
Attention-decit/hyperactivity disorder;
ACR, Anterior corona radiata; ALIC, Anterior limb of internal cap-
sule; BCC, Body of corpus callosum; CGC, Cingulum (cingulate gyrus);
CGH, Cingulum (hippocampus); EC, External capsule; FXST, Fornix
(cres)/Stria terminalis; GCC, Genu of corpus callosum; IFO, Inferior
fronto-occipital fasciculus; PCR, Posterior corona radiata; PLIC, Posterior
limb of internal capsule; PTR, Posterior thalamic radiation (include optic
radiation); RLIC, Retrolenticular part of internal capsule; SCC, Splenium
of corpus callosum; SCR, Superior corona radiata; SFO, Superior fronto-
occipital fasciculus; SLF, Superior longitudinal fasciculus; SS, Sagittal
stratum.
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Supplementary Table 1: Full name and description of DTI parameters.
DTI parameter Full name Description
FA fractional anisotropy a summary measure of WM integrity
MD mean diffusivities magnitude of absolute directionality
AD(L1) axial diffusivities eigenvalue of the principal diffusion direction
RD radial diffusivities average of the eigenvalues of the two secondary directions
MO mode of anisotropy third moment of the tensor
L2, L3 two secondary diffusion direction eigenvalues
Supplementary Table 2: Full name of 18 WM tracts.
WM tract Full name
ACR Anterior corona radiata
ALIC Anterior limb of internal capsule
BCC Body of corpus callosum
CGC Cingulum (cingulate gyrus)
CGH Cingulum (hippocampus)
EC External capsule
FXST Fornix (cres)/Stria terminalis
GCC Genu of corpus callosum
IFO Inferior fronto-occipital fasciculus
PCR Posterior corona radiata
PLIC Posterior limb of internal capsule
PTR Posterior thalamic radiation (include optic radiation)
RLIC Retrolenticular part of internal capsule
SCC Splenium of corpus callosum
SCR Superior corona radiata
SFO Superior fronto-occipital fasciculus
SLF Superior longitudinal fasciculus
SS Sagittal stratum
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Supplementary Table 3: The 20 significant associations between the
PRS of four psychiatric disorders and brain WM tracts in the UK Biobank
dataset (FDR controlled at 0.05 level). Raw R2 stands for the proportion
of variance in the DTI parameter that can be explained by psychiatric
disorder PRS. Corrected R2s are the ones after correction according our
formulas. Seven DTI parameters are considered on each WM tract: FA,
fractional anisotropy; MD, mean diffusivities; L1(AD): axial diffusivities,
also the eigenvalue of the primary diffusion direction; RD, radial diffusivi-
ties; MO, mode of anisotropy; L2 and L3, two secondary diffusion direction
eigenvalues.
Disorder-Tract-DTI Estimate Std. Error P -value Raw R2 (×100%) Corrected R2 (×100%)
ADHD-ACR-L2 -0.0317 0.0105 0.0026 0.1006 4.3005
ADHD-ALIC-MO 0.0311 0.0104 0.0026 0.0970 4.7888
ADHD-FXST-L1 -0.0373 0.0110 0.0007 0.1392 5.9635
ADHD-FXST-MO -0.0337 0.0104 0.0012 0.1133 4.8436
ADHD-PCR-L3 -0.0319 0.0108 0.0031 0.1017 4.9767
ADHD-PCR-RD -0.0325 0.0110 0.0030 0.1055 4.8518
ADHD-PLIC-FA 0.0388 0.0113 0.0006 0.1509 5.4437
ADHD-PLIC-L2 -0.0431 0.0113 0.0001 0.1862 6.6136
ADHD-PLIC-L3 -0.0361 0.0110 0.0010 0.1306 5.4399
ADHD-PLIC-MD -0.0330 0.0109 0.0024 0.1089 5.6350
ADHD-PLIC-RD -0.0444 0.0112 0.0001 0.1974 7.2696
ADHD-PTR-L1 -0.0351 0.0112 0.0018 0.1233 5.6933
ADHD-PTR-MD -0.0351 0.0109 0.0012 0.1233 6.1215
ADHD-RLIC-MD -0.0336 0.0109 0.0021 0.1127 5.6610
ADHD-SCC-FA 0.0331 0.0113 0.0033 0.1098 4.8173
ADHD-SCC-L2 -0.0367 0.0113 0.0011 0.1347 6.4249
ADHD-SS-L1 -0.0338 0.0111 0.0022 0.1142 5.2611
BD-BCC-L1 0.0331 0.0109 0.0023 0.1092 4.7963
SCZ-BCC-L1 0.0363 0.0109 0.0009 0.1315 2.8821
SCZ-IFO-L1 0.0341 0.0113 0.0025 0.1163 3.4237
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